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Proteolytic enzymes are crucial for a variety of biological processes in organisms ranging
from lower (virus, bacteria, and parasite) to the higher organisms (mammals). Proteases
cleave proteins into smaller fragments by catalyzing peptide bonds hydrolysis. Proteases
are classified according to their catalytic site, and distributed into four major classes:
cysteine proteases, serine proteases, aspartic proteases, and metalloproteases. This
review will cover only cysteine proteases, papain family enzymes which are involved in
multiple functions such as extracellular matrix turnover, antigen presentation, processing
events, digestion, immune invasion, hemoglobin hydrolysis, parasite invasion, parasite
egress, and processing surface proteins. Therefore, they are promising drug targets
for various diseases. For preventing unwanted digestion, cysteine proteases are
synthesized as zymogens, and contain a prodomain (regulatory) and a mature domain
(catalytic). The prodomain acts as an endogenous inhibitor of the mature enzyme. For
activation of the mature enzyme, removal of the prodomain is necessary and achieved
by different modes. The pro-mature domain interaction can be categorized as protein–
protein interactions (PPIs) and may be targeted in a range of diseases. Cysteine protease
inhibitors are available that can block the active site but no such inhibitor available
yet that can be targeted to block the pro-mature domain interactions and prevent it
activation. This review specifically highlights the modes of activation (processing) of
papain family enzymes, which involve auto-activation, trans-activation and also clarifies
the future aspects of targeting PPIs to prevent the activation of cysteine proteases.
Keywords: auto-catalysis, trans-activation, pH sensor, prodomain, zymogen, protein–protein interaction
INTRODUCTION
Cysteine proteases are present in all living organisms. Besides their fundamental functions of
catabolism and protein processing, cysteine proteases perform diverse functions (Chapman et al.,
1997; Vasiljeva et al., 2007). Cysteine proteases of parasites play key role in hemoglobin hydrolysis,
blood cell invasion, egress, surface proteins processing (Lecaille et al., 2002; Sajid and McKerrow,
2002; Sijwali and Rosenthal, 2004). In 1937, papain was the ﬁrst cysteine protease isolated and
characterized from Carica papaya (Walsh, 2014). Papain and cathepsins belong to the most
abundant family of the cysteine proteases. In mammals, a main group of cysteine proteases is
known as lysosomal cathepsins (McGrath, 1999). The name cathepsin, is derived from the Greek
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kathepsein (to digest; Willstätter and Bamann, 1929).
Bioinformatics analysis reveals that human genome encodes
11 cysteine cathepsins, i.e., the cathepsins B, C, F, H, K, L,
O, S, V, X, and W, existing at the sequence level (Rossi et al.,
2004). Cathepsins and other cysteine proteases from parasites
as well as viruses may become good targets for major diseases
such as arthritis, osteoporosis, AIDS, immune-related diseases,
atherosclerosis, cancer, and for a wide variety of parasitic diseases
such as malaria, amebiasis, chagas disease, leishmaniasis, or
African sleeping sickness (Petrov et al., 2000; Lecaille et al., 2002;
Gills et al., 2007; Salminen-Mankonen et al., 2007; Hirai et al.,
2013).
In parasitic disease like malaria, cysteine proteases (falcipains)
of Plasmodium falciparum speciﬁcally involve in hemoglobin
degradation, parasite egress, processing surface proteins,
therefore, function as a promising new drug targets (Francis
et al., 1997; Rosenthal et al., 2002). P. falciparum expresses
four papain-like cysteine proteases named as falcipain-1, 2,
2′ and 3. Falcipain-2 and -3 are the major cysteine proteases
of P. falciparum involved in hemoglobin hydrolysis (Pandey
et al., 2004, 2005; Sijwali and Rosenthal, 2004; Sijwali et al.,
2006).
For preventing unwanted protein degradation, like other
proteolytic enzymes (serine, aspartic, and metalloproteases),
cysteine proteases are also synthesized as inactive precursors (or
zymogens). Cysteine protease zymogens contain a prodomain
that block access of substrate to the active site (Coulombe et al.,
1996). Besides acting as an endogenous inhibitor (Pandey et al.,
2004, 2009), prodomain may have additional roles in protein
folding and or intracellular sorting (Tao et al., 1994; Cuozzo et al.,
1995; Pandey et al., 2004). Activation of an enzyme from its
zymogen generally takes place within a subcellular compartment
or the extracellular environment, in which the particular enzyme
performs its biological function. Zymogen conversion may be
accomplished by accessory molecules (e.g., trypsinogen convert
into trypsin in presence of ca2+), by an auto catalytic process
with requirement of a signiﬁcant drop in pH and by other
enzymes as in trans-activation (Kay and Kassell, 1971; Mason
and Massey, 1992). This review highlights the diﬀerent modes of
activation in cysteine proteases and their future aspects.
Cysteine Proteases
Cysteine proteases contain a Cys–His–Asn triad at the active
site. A histidine residue, presents in the active site act as
proton donor and enhance the nucleophilicity of the cysteine
residue (Figure 1). Nucleophilic cysteine residue attacks to
the carbon of the reactive peptide bond, producing the ﬁrst
tetrahedral thioester intermediate in the reaction with release
of an amine or amino terminus fragment of the substrate
(Coulombe et al., 1996). This intermediate is stabilized by
hydrogen bonding between the substrate oxyanion and a
highly conserved glutamine residue. Subsequently, the thioester
bond is hydrolyzed to produce a carboxylic acid moiety from
the remaining substrate fragment. Based upon a sequence
analysis of papain-like cysteine protease family was divided into
two distinct subfamilies, cathepsin-L-like and cathepsin-B-like
proteases, which can be distinguished by the structure of the
prodomain and the mature domain (Coulombe et al., 1996;
Turk et al., 1996). A third ‘F-like’ group was also proposed
based on phylogenetic analyses showing that cathepsins F and
W prodomains share a speciﬁc sequence pattern, ERFNAQ
(Martinez and Diaz, 2008). The main diﬀerence between
the sub-families exists in the sequence of the prodomains
and their length (Dieter Bromme, 2011) (Figure 2). The
prodomain of the cathepsin L subfamily (cathepsins L, V, K,
S, W, F, and H) contain a prodomain of about 100 residues,
with two conserved motifs: a highly conserved ERFNIN and
GNFD motifs. An ERFNIN motif is lacking in cathepsin B,
C, O, and X. Cathepsin B has a characteristic feature with
‘occluding loop’ which provide carboxydipeptidase activity (Turk
et al., 1996). Falcipains, malarial cysteine proteases belongs to
cathepsin L-like subfamily. Falcipains, malarial cysteine proteases
have some unusual features, including large prodomains,
predicted membrane-spanning sequences within the prodomains
(Rosenthal, 2011).
Zymogen Structure and Mechanism of
Inhibition
The mature enzymes or active enzymes of the family share a
well-known fold of papain-like which consists of two domains:
N-terminal helical domain and a C-terminal β-sheet domain.
Catalytic Cys, His, and Asn are contributed by these two
domains. These residues are located in the substrate binding cleft
(Figure 1).
The cathepsins B and L are well characterized papain-like
enzymes, synthesized as zymogens (Coulombe et al., 1996;
Turk et al., 1996). The prodomain of cathepsin L (96 amino
acids) has an N-terminal globular domain that consist of three
α-helices and their connecting loops, an extended structure
followed by globular domain which traverse the substrate binding
cleft in a reverse orientation (N→C-terminal) with respect to
substrate that are cleaved and prevent access to active site.
The prodomain and the mature domain interact via many
residues (Phe56p, Phe63p, phe71p, Tyr146, and Tyr151; p stands
for prodomain) lying at their interface (Coulombe et al., 1996).
These residues are crucial for the activation of the mature
enzyme. In falcipain-2, a mutation at prodomain residue Phe60p
(equivalent to Phe56p of prodomain of cathepsin L) has shown
inability to undergo auto-activation at its optimum pH (5.5)
(Sundararaj et al., 2012). A conserved Gly77p residue helps
in bringing the prodomain deep inside the catalytic cleft, in
such a way that an oxyanion hole forms a hydrogen bond to
Asn76p, and indirectly prevent access to catalytic cysteine for
the catalysis. The prodomain of cathepsins B has similar fold
as procathepsin L, but have some diﬀerences such as deletion
of 30-residues from the N-terminal makes the prodomain short
as compared to procathepsin L, orientation of the helices α2p
and α3p are diﬀerent due to presence of an ‘occluding loop’ a
characteristic feature of the cathepsins B subfamily and absence
of conserved ERFNIN motif (Turk et al., 1996). Due to presence
of an occluding loop, cathepsins B subfamily is able to cleave
dipeptide units from the carboxyl-terminal of the substrate
(Figure 3).
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FIGURE 1 | Structure of the mature domain. Structural representation of cysteine protease with the mature domain (Orange) showing active site residues; Cys,
His, and Asn (stick); PBD ID: 3PNR.
FIGURE 2 | Schematic representation of cysteine proteases pro and mature domain. In this schematic representation, cysteine proteases have classified
according to their peptidase property and depicted length of the domains.
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FIGURE 3 | Comparison of procathepsin L and B. Structural representation of the procathepsin L (orange) (PDB ID: 1CS8) ERFNIN (red) and GNFD (blue) motifs
are shown. The prodomain of cathepsin B (cyan) (PDB ID: 1MIR) with GNFD-motif (blue), occluding loop (purple), and long carboxy terminus (green) are mentioned in
the structure.
Although there are diﬀerences but both the classes of enzymes
have conserved mode of inhibition and share some common
features such as interactions between the loop and the conserved
hydrophobic residues in the prodomain and a conserved Gly
residue near to the catalytic Cys residue. A conserved Gly in the
hydrophobic pocket facilitate the C-terminus of the prodomain
to push deep into the catalytic cleft and inhibit the catalytic site
to perform catalysis. The prodomains exhibit a limited selectivity
of inhibition against their related enzymes (Groves et al., 1998).
First evidence for prodomains acting as selective inhibitors of
cathepsin was seen when recombinant cathepsin L prodomain
inhibited cathepsin L with lower Ki (0.088 nM) and cathepsin
S with higher Ki (44.6 nM), whereas no inhibition of papain or
cathepsin B was observed (Carmona et al., 1996). Besides acting
as an endogenous inhibitor, prodomain are also involved in some
other functions such as refolding and intracellular sorting of the
enzyme. Like other papain-family cysteine proteases, prodomain
of falcipain-2 is a potent inhibitor of the enzyme (Pandey et al.,
2004). The C-terminal portion of the prodomain that includes
“ERFNIN” and “GNFD” motifs, appear to mediate inhibition
in many papain family proteases. The N-terminal portion of
the prodomain mediates traﬃcking of the enzyme to the food
vacuole, a site for the hemoglobin digestion (Subramanian et al.,
2007, 2009). Many studies reported that whole prodomains are
involved in correct folding of the enzyme while in falcipain-2
and falcipain-3, only N-terminal motif with 15 amino acid of
the mature domain is required for refolding of enzyme (Pandey
et al., 2004). The C-terminal part of the prodomain is suﬃcient
for falcipains inhibition (Pandey et al., 2009; Pandey and Dixit,
2012).
ACTIVATION MECHANISMS
Once reaching to its speciﬁc compartment, processing of the
enzyme starts, which include cleavage of the prodomain and
activation of the mature enzyme (Hasilik et al., 2009). In
processing of cysteine protease, pH change has great importance.
In lysosomes or food vacuoles, enzymes get activated by
controlled proteolysis which involves autocatalysis or trans-
activation (Schroder et al., 2010). Based upon previous studies
on procathepsin L, a pH-dependent conversion may start with
the disruption of the conserved salt bridges (Asp65→Arg21
and Gln70→Arg31) within the prodomain (Vernet et al., 1995).
Disruption of the salt bridges due to protonation of the
carboxylate group at the lower pH could conceivably trigger the
disruption of the hydrophobic core of the prodomain, leading to
dissociation of the prodomain from the active site, and thereby
initiating the process of auto catalytic processing (Vernet et al.,
1995).
Due to presence of an occluding loop in procathepsin B,
mature domain undergoes signiﬁcant conformation changes
during the processing. In contrast, procathepsin L-like papain-
family proteases do not have occluding loop, therefore, the
mature domain is not expected to undergo signiﬁcant change
during the processing (Coulombe et al., 1996; Cygler et al., 1996).
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Further, structures of other procathepsins provided insight
in understanding zymogen activation. The crystal structures of
human and rat procathepsin B (Cygler et al., 1996; Turk et al.,
1996), human procathepsin L (Coulombe et al., 1996), human
procathepsin K (Sivaraman et al., 1999), and human procathepsin
X (Sivaraman et al., 2000) showed that the prodomain folds on
the surface of the enzyme in an extended conformation and
runs through the active-site, in the opposite direction to the
substrate, thereby blocking the access of the active site. In the
structure of most proenzymes, salt bridges, hydrogen bonding,
and hydrophobic interactions within the prodomain and between
the pro-mature domains exist. The exception is the structure
of cathepsin X, in which the prodomain binds covalently to
the mature enzyme with a disulphide bridge between cysteine
residue in the prodomain and active site cysteine, thus preventing
any auto-activation (Sivaraman et al., 2000). However, it can
be processed in vitro under reducing conditions by cathepsin L
(Nagler and Menard, 1998).
Processing or zymogen activation of proteases may exhibit via
diﬀerent modes such as auto-activation and trans-activation or
both (Nishimura et al., 1989; Menard et al., 1998). Auto-catalysis
involves the cleavage of prodomain by catalytic site present inside
the catalytic cleft of the enzyme under the inﬂuence of pH change
(Menard et al., 1998). However, trans-activation involve cleavage
by the another molecule of the same enzyme or some other
proteases that cleave within the residues lying at the junction
of the prodomain and the mature domain such as pepsin,
aspartic cathepsin D, and legumain/asparaginyl endopeptidase
(Nishimura et al., 1989; Menard et al., 1998). It is reported
that some proteases have unusual kind of activation such as
Cathepsin D (Laurent-Matha et al., 2006). This review further
highlights diﬀerent modes of processing of cysteine protease
zymogens.
Activation by Auto-processing
Auto-catalysis is a common mode of activation of cysteine
proteases itself from their zymogens under the inﬂuence of pH
change (acidic pH). The pH has great importance in auto catalytic
mode of activation. The pH change triggers the disruption of
important interactions between the prodomain and the mature
domain, thereby make accessible the cleavage site within the
prodomain loop to the active site. An N-terminal prodomain get
cleaved oﬀ from the whole enzyme by active site and enzyme get
activated (Figure 4).
Early studies suggested that autocatalytic processing is a
unimolecular process (Rowan et al., 1992; Mach et al., 1994)
and, while others proposed inter-molecular and intra-molecular
mechanisms (McQueney et al., 1997; Menard et al., 1998).
However, this dilemma has been resolved that the auto-
activation of cathepsins is a combination of a unimolecular
and a bimolecular process (Rozman et al., 1999). For example,
procathepsin B possesses a low catalytic activity that is not
suﬃcient to trigger the auto catalytic activation. Low activity of
cathepsin B is the result of the prodomain dissociation from the
FIGURE 4 | Model (illustrative) for auto-activation of falcipain-2 (FP2), a malarial cysteine protease. The prodomain of FP2 removed and enzyme get
activated under the influence of low pH. Inset shows crucial salt bridges (green-dotted circles) and hydrophobic (purple-dotted circle) interactions are required for
auto-activation. Model was generated via Modeler by taking known structures as templates (PDB ID; 3PNR and 1CS8). All figures are prepared using PyMOL.
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active-site cleft as the ﬁrst step, which is a unimolecular step
(Pungercar et al., 2009). In the next step, which is bimolecular,
this catalytically active cathepsin B molecule processes and
activates another procathepsin B molecule in one or more steps.
The mature cathepsin B molecules generated in this way then
initiate a chain reaction leading to a rapid activation of the
remaining procathepsin B molecules. Cysteine proteases based
on their cleavage property can be categorized into two groups;
endopeptidase and exopeptidase (Table 1). Endopeptidases such
as the cathepsins B, H, L, S, and K can be activated by
autoactivation, whereas the true exopeptidases, such as the
cathepsins C and X, needed endopeptidases, such as the
cathepsins L and S (Dahl et al., 2001), for their activation
(Table 1; Figure 2) (Dieter Bromme, 2011). Mutational studies
of cathepsin K conﬁrmed its mode of activation by autocatalysis.
An active site Cys139 to Ser mutant of procathepsin K failed
to undergo activation but could be processed fully when
incubated with wild-type procathepsin K (McQueney et al.,
1997).
The activation of cysteine proteases are modulated by the
glycosaminoglycans (GAGs) such as sulfated GAGs, heparin,
heparan sulfate, and chondroitin sulfates A, B, C, E, and other
negatively charged polysaccharides, e.g., dextran sulfate. Various
studies have suggested the involvement of GAGs in the in vivo
processing of cathepsins (Caglic et al., 2007; Novinec et al.,
2014). Similarly, GAGs accelerate the auto catalytic activation
of cathepsin L and B, including at neutral pH. Studies reported
that GAGs interact with cathepsin B via electrostatic interactions,
being negatively charged, GAGs interact with the positively
charged residues present in the occluding loop of the mature
domain and the prodomain of the cathepsin B. GAGs binding
induce conformation changes in the prodomain of cathepsin
B, which unmask the active site for the catalysis of the other
procathepsin B molecules (Figure 5) (Caglic et al., 2007). Further
GAGs role in activation of cathepsins was conﬁrmed by the auto-
activation of procathepsin S at neutral pH (Vasiljeva et al., 2005).
However, a recent ﬁnding with cathepsin S at high concentration
of chondroitin-4-sulfate (C4S) exhibits a decelerating eﬀect of
GAGs on activation (Sage et al., 2013). Besides the activation of
cysteine proteases, GAGs also have been found to aﬀect both the
activity and stability of the mature cysteine cathepsins (Almeida
et al., 1999; Li et al., 2000). Most of the knowledge about the
GAGs role in regulation of cathepsins came from the studies of
papain. A hyperbolic kinetic proﬁle of cathepsin K in presence
of GAGs suggest their interactions outside the active site, may
TABLE 1 | Types of cysteine proteases on the basis of cleavage property
and their mode of activation.
Enzyme cleavage
property
Enzyme (cysteine
protease)
Activation
mode
Endopeptidase Cathepsin L, S, K,
V, F, Falcipains
Auto-activation
Exopeptidase Cathepsin C, X, Trans-activation
Endo and
Exopeptidase
Cathepsin B, H Auto-activation
be via allosteric mechanisms (Li et al., 2008; Novinec et al.,
2010).
Cysteine proteases play important role in life cycle of
parasitic organism. Parasites also express cathepsin L and B
like proteases. Falcipains, well characterized cathepsin L-like
cysteine proteases from P. falciparum, synthesize as zymogens
and get activated by auto activation in acidic environment
(pH 5–5.5). Sundararaj et al. (2012), from our group revealed
that prodomain-mature domain of falcipain-2 and falcipain-
3 interacts via salt bridges and hydrophobic interactions.
Mutagenesis study showed that two salt bridges (Arg185–Glu221,
Glu210–Lys403) in falcipain-2, and one salt bridge (Arg202–
Glu238) in falcipain-3, and hydrophobic interactions present both
in falcipain-2 (Phe214–Trp449Trp 453), and falcipain-3 (Phe231–
Trp457Trp 461) also play important roles in the activation of
these enzymes (Figure 4). Mutants were unable to undergo
autocatalysis, although, activation can further be achieved by
trans-activation (Sundararaj et al., 2012).
Auto activation of cysteine proteases from other parasitic
organisms have been proposed by many studies (Dalton et al.,
1997; Stack et al., 2008). In vitro study about Fasciola hapatica
procathepsin L1 (FhproCL1) demonstrated that auto activation
can occur within wide pH range 4.5–7.3 (Lowther et al.,
2009). Active site mutant of F. hepatica (FhproCL1Gly25)
cannot undergo auto-catalytic processing (Collins et al., 2004).
Schistosoma mansoni, a parasitic worm causing Schistosomiasis
(also known as bilharzia) expresses papain-like cysteine proteases
including cathepsins (B1, L1, L3, F, and C) and an aspartic
protease (cathepsin D) in the parasite gut, function in an
acidic pH environment (Gotz and Klinkert, 1993; Dalton
and Brindley, 1996). A number of reports have shown that
both parasite and mammalian cysteine proteases can be
auto catalytically activated in vitro from zymogen to mature
enzyme by reducing the pH of the solution (Lowther et al.,
2009).
Activation by Trans-processing
Trans-activation involve cleavage by another molecule of the
same enzyme (Figure 6) or some other proteases that cleave
within the residues lying at the junction of prodomain
and mature domain such as pepsin, Cathepsin D, and
legumain/asparaginyl endopeptidase (Figure 7) (Dalton and
Brindley, 1996; Dahl et al., 2001). Cathepsin C and X
require an endopeptidase such as cathepsins L or S for their
activation. Moreover, cathepsin S prodomain was found to be
rapidly degraded by cathepsin L. In contrast to most other
cathepsins, cathepsin C was not capable of auto activation,
even addition of the mature cathepsin C. This is consistent
with procathepsin X, which is also an exopeptidase. Cathepsin
X prodomain binds covalently to the mature enzyme with a
disulphide bridge between cysteine residues in the prodomain
and the active-site cysteine, thus preventing any auto-catalytic
processing (Sivaraman et al., 2000). However, it can be processed
in vitro under reducing conditions by cathepsin L and S
(Figure 7) (Dahl et al., 2001). Falcipains zymogens can be
trans-activated by their mature enzymes. In other parasites,
cysteine proteases can be trans-activated by their mature enzymes
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FIGURE 5 | Mechanism of procathepsin B auto-activation in the presence of glycosaminoglycans (GAGs). GAG molecules bind to the occluding loop and
the prodomain of cathepsin B molecule via electrostatic interactions. GAGs binding induce conformational change in procathepsin B (PDB ID: 1MIR), which
unmasks the active site and enable the access of procathepsin B molecule.
FIGURE 6 | Model (illustrative) for trans-activation by same enzyme molecule. Trans-activation of the enzyme by other active molecule of same enzyme is
shown the figure. Initially, single molecule of enzyme get activated under low pH, thereafter these active molecule further activate the other inactive enzymes and
initiate a chain reaction. Model was generated via Modeler by taking known structures as templates (PDB ID; 3PNR and 1CS8).
and asparaginyl endopeptidase, a clan CD cysteine protease
that cleaves C-terminal to asparginyl (Asn) residues (Dalton
and Brindley, 1996). Pre-activated wild F. hepatica cathepsin
L (FhproCL1) enzyme is able to trans-process (FhproCL1)
zymogens at speciﬁc cleavage site Leu12–Ser11↓His10motif and
thus increase rate of activation exponentially. Mutational study
has shown that alteration of the motif to a Pro12–Ser11↓His10
prevents or slows down FhproCL1 activation (Stack et al.,
2008). A study by Dalton et al. proposed that Schistosome
asparaginyl endopeptidase (SmAE) is responsible for trans-
processing of the cysteine proteases involved in the hemoglobin
degradation in Schistosome (Dalton and Brindley, 1996; Sajid
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FIGURE 7 | Model (illustrative) of trans-activation by other enzyme molecule. Procathepsin X (PDB ID: 1DEU) consists covalently linked prodomain (blue).
Cathepsin L (violet) (PDB ID: 1CS8) trans-activate procathepsin X by cleaving the prodomain and releasing an active cathepsin X (green).
et al., 2003). Furthermore, Fasciola hepatica cathepsin B also
have preserved asparaginyl endopeptidase-processing site at the
pro-mature domain junction and SmAE was also shown to trans-
process F. hepatica cathepsin B. Interestingly, the prodomain
of O. viverrini cathepsin F (Ov-CF-1) lacks the conserved
asparagine residues found in other homologues and could
not be trans-processed by Opisthorchis viverrini asparaginyl
endopeptidase. However, recent studies shown O. viverrini
cathepsin B (Ov-CB-1) is capable of trans-activating cathepsin
F (Ov-CF-1) at a speciﬁc site between the prodomain and the
mature enzyme (Sripa et al., 2010).
Activation by Uncommon Mode of
Processing
Number of studies reported that both parasite and mammalian
cysteine proteases can be auto activated in vitro from zymogen
to mature enzyme by reducing the pH of solution (Dalton et al.,
2009), but some studies reported uncommon mode of activation
which involves partial auto-activation followed by full activation
by an enzyme.
The schistosome cathepsin B1 (SmCB1) is a unique in terms
of activation, as the zymogen does not auto catalytically activate
at low pH (Sajid et al., 2003; Dalton et al., 2009). Crystal
structure of SmCB1 zymogen has solved and revealed another
activation trigger which involved sulfate polysaccharides (Dalton
and Dvorak, 2014). The prodomain of the SmCB1 contains
a short and unique helix, α-3p which contains Schistosome
asparaginyl endopeptidase (SmAE) cleavage site and a heparin-
motif (LRRTRRP). A heparin-motif of the prodomain is involved
in interaction with the mature enzyme and makes α-3p an
ideal point of interaction for sulfated polysaccharides-like
dextran sulfate. At low pH, SmCB1 zymogen auto catalytically
produces an inactive intermediate clipping oﬀ 38 residues of
the prodomain, but this does not fully expose the active site.
Adding dextran sulfate to the reaction mixture facilitates the
pinch oﬀ few more residues in the vicinity of substrate binding
site, to produce an active intermediate. This ﬁnally, leads to
processing of SmCB1 to the mature enzyme via trans-activation
by SmAE. The binding of sulfated polysaccharides to an intact α-
3p heparin-binding motif is required for complete processing of
the SmCB1.
Cathepsin-D, an aspartic protease also synthesize as inactive
enzyme. The activation of cathepsin-D, an intermediate
mechanism had been proposed, i.e., a partial auto-activation
followed by a ﬁnal processing by other enzymes. Studies have
shown that the processing of endocytosed procathepsin-D is
also independent of its catalytic function and requires cysteine
proteases for its activation (Laurent-Matha et al., 2006).
DISCUSSION
Proteases have been categorized into groups on the basis of the
catalytic mechanism used during the hydrolytic process such as
cysteine, serine, aspartate, and metalloproteases. For preventing
unwanted degradation, cysteine proteases are synthesized as
inactive enzymes and removal of the prodomains lead to
the activation of the enzymes. Each class has their own
mechanism of inhibition and activation. Main concept of
inhibition is that prodomain sterically block the pre-formed
active site and inhibit the access to the substrate (Khan and
James, 1998). Generally zymogens get self-activated in low
pH upon reaching to the speciﬁc compartments and it is
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reported that salt bridges plays important role in stabilization
of pro-mature domain interactions at neutral pH. Upon
reaching to speciﬁc compartment, prodomain are removed
by autocatalysis or by other enzymes (trans-activation). Auto-
activation is most economical mode of conversion since no
involvement of other enzymes. However, trans-activation by
other enzyme is required to enhance the conversion rate in
critical conditions. For example, cathepsins F, a liver ﬂuke
(O. viverrini) enzyme, secreted as an inactive zymogen that auto-
catalytically processes and activated to a mature enzyme at pH
4.5, but studies shows that it can also be activated via trans-
processing by cathepsins B1 at pH 5.5, where it is unable to
activate auto-catalytically. Both enzymes (cathepsin B1 and F1)
work together to degrade the host tissue and contributing to
develop liver-ﬂuke-associated chalangiocarcinoma (Sripa et al.,
2010).
In vivo studies reported, after removal, prodomains are
hydrolyzed and ensure that the activation process is irreversible
(Rozman et al., 1999; Turk et al., 2012). Although, in vitro study
by Sijwali et al. (2002) showed that the prodomain of falcipain-
2 is a potent, competitive, and reversible inhibitor of the active
product. Table 2 summarizes the mechanism of inhibition and
activation of cysteine proteases.
The pro-mature domain interactions are categorized in
protein–protein interactions (PPIs). Presently, targeting PPIs is
an attractive and promising area of research. A special interest
in cysteine proteases as targets derives from the recognition
that they are critical to the life cycle or pathogenicity of
many parasites. This functional diversity is derived from their
unique nucleophilicity, adaptability to diﬀerent substrates,
stability in diﬀerent biological environments, and their
regulations. Parasite derived cysteine proteases play key
roles in hemoglobin hydrolysis, breakdown of RBC proteins,
immunoevasion, enzyme activation, virulence, tissue, and
cellular invasion as well as excystment, hatching, and molting
(Sajid and McKerrow, 2002; Sijwali and Rosenthal, 2004).
Previous study by Sundararaj et al. (2012) showed that the
prodomain-mature domain interactions are essential for the
auto-activation of the falcipains and their mutation impaired
the enzyme ability to undergo activation by autocatalysis.
Blocking of such interactions will cease the parasite growth
due to inactivity of these proteases. Therefore, designing
inhibitors against such interactions are important new
targets.
Future Aspects
In this review, we have discussed targeting the cysteine proteases
before activation, which may prevent their involvement in
various diseases. The possible ways are:
1. Targeting promature domain interactions which are
important for the activation.
2. Targeting the residues involved in pH sensing and
activation.
Pro-mature domain interactions can be categorized as PPIs.
Earlier targeting PPIs were not in trend due to technological
hurdles. Studies have demonstrated that small molecules can
disrupt the large and complex protein interactions by interacting
with interface residues, known as hot-spots (Mullard, 2012;
Pandey, 2013). In a study of a herpes virus protease, researchers
developed a small-inhibitor that target to block the interactions of
two monomers, and prevent it forming the active dimer interface
(Shahian et al., 2009). Recently, our group is also focusing on PPIs
crucial for activation of enzyme in malarial cysteine proteases.
Our earlier reports suggested that salt bridges and hydrophobic
interactions between pro-mature domains were crucial for the
activation of malarial cysteine proteases (Sundararaj et al., 2012),
and disruption of these interactions lead to failure of the
activation of enzymes. Therefore, it would be possible to control
the growth of the parasites and other harmful organisms by
blocking the processing of cysteine proteases. In our lab, we have
screened some inhibitors, which are able to block the processing
of falcipains and further detail characterization and kinetics of
potential inhibitors are underway.
The pH has great importance in activation of zymogens of
proteases in speciﬁc compartment (Schroder et al., 2010). It
is very interesting, how pH triggers the activation? Inactive
enzyme move through diﬀerent compartments having varying
pH gradient and get activated inside the speciﬁc compartment
under the inﬂuence of pH change. Therefore, it is suggests that
there are some sensors residues who can sense the pH change and
trigger activation process (Feliciangeli et al., 2006). It is reported
that folding and activation of furin, a calcium-dependent serine
endoprotease, occurs through pH and compartment-speciﬁc
auto-proteolytic steps. A conserved His69 of prodomain act as
pH sensor that regulates the compartment-speciﬁc cleavages
of the prodomain. Although, structural modeling combined
with mathematical modeling and molecular dynamic simulations
suggested that His69 does not contribute directly to the
TABLE 2 | Cysteine protease with their inactivation and activation modes.
Enzyme class Inactivation mechanism Activation/Processing
Cysteine protease
(Cathepsins and parasitic )
• Steric block of the active
site by prodomain
• Generally via auto-activation but some are activated by
trans-activation; e.g., cathepsin C and X
• Disruption of salt bridges, hydrophobic interactions, e.g., falcipain-2
and falcipain-3
• No conformational change in the mature domain during activation in
cathepsin L-like cysteine proteases but cathepsin B-like undergo
significant change due to occluding loop
• Some proteases are involved in trans-activation, i.e., asparaginyl
amino-peptidase
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prodomain–enzyme interface. But, rather, triggers movement of
a loop region in the prodomain that modulates access to the
cleavage site and thus, allows the tight pH regulation of furin
activation (Feliciangeli et al., 2006; Williamson et al., 2013).
Like serine proteases, cysteine proteases also follow the similar
mechanism to get activated auto-catalytically under the inﬂuence
of compartment speciﬁc pH change. The cysteine proteases could
have pH sensor residue like furin that sense pH change and
trigger activation events. Taking this idea, we performed sequence
alignment of the prodomain of the cysteine proteases among
the organisms including malarial cysteine proteases and found
a conserved His residue for further exploring the role as a pH
sensor in processing of malarial cysteine proteases. Interestingly,
our initial results support that notion that pH sensor also play
important role in processing of falcipains. Therefore, disturbing
the PPIs and designing inhibitor based on such interactions are
futuristic approaches for preventing the pathogenic diseases, and
they may have least sensitive to drug resistance.
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